MX-WOUND · Transforming chronic wound care with targeted MXene-based antibacterial and regenerative technologies
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2026-09-01 → 2030-08-31
- Финансиране от ЕС
- 1 588 170 €
- Участници
- 10
- Схема
- HORIZON-TMA-MSCA-SE
Линиите свързват координатора с партньорите.
Накратко на български
Нанотехнологиите с MXene се използват за създаване на специални превръзки, които унищожават бактерии чрез светлина и стимулират възстановяването на тъканите. Това помага при лечението на хронични рани, при които стандартните антибиотици вече не действат ефективно.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
The MX-WOUND project aims to revolutionize chronic wound care by developing a first-of-its-kind multimodal antibacterial and regenerative platform powered by MXene nanotechnology. Conventional treatments are increasingly ineffective due to multidrug-resistant infections and insufficient regenerative support. MX-WOUND addresses these challenges by uniting targeted antibacterial therapy, photothermal modulation, and regenerative stimulation into a single, clinically translatable solution.MXenes, a cutting-edge class of 2D transition metal carbides and nitrides, will be polydopamine-coated and conjugated with MRSA-specific antibodies to ensure highly selective bacterial targeting. Combined with near-infrared light-triggered photothermal therapy, this approach enables rapid pathogen eradication with minimal damage to surrounding tissues. In parallel, electrospun and hybrid-spun nanofibrous scaffolds will be engineered to deliver mesenchymal stem cell-derived secretome, promoting angiogenesis, immune modulation, and tissue repair to accelerate wound closure.MX-WOUND unites leading academic, clinical, and industrial partners from Europe, Ukraine, and the USA in a highly interdisciplinary network. The project follows a rigorous translational pipeline—MXene synthesis and functionalization, scaffold fabrication, in vitro validation, and preclinical in vivo testing—ensuring robustness, scalability, and clinical relevance.Beyond scientific innovation, MX-WOUND will train a new generation of researchers through cross-sectoral secondments, industry placements, and mentoring. By integrating nanotechnology, precision photothermal therapy, and regenerative medicine, MX-WOUND will deliver a transformative, antibiotic-free therapy for chronic wounds, improve patient outcomes, and help combat the global threat of antimicrobial resistance.
Оригинален текст от CORDIS (на английски).
Участници
- LATVIJAS UNIVERSITATE · RIGAКоординаторЛатвия
- FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV · MunchenГермания
- INSTYTUT IMMUNOLOGII I TERAPII DOSWIADCZALNEJ IM LUDWIKA HIRSZFELDA PAN · WROCLAWПолша
- MATERIALS RESEARCH CENTER · KievУкрайна
- MB SENSOGRAFA · VilniusЛитва
- NANOSPACE TECHNOLOGY SRO · MostЧехия
- SUMY STATE UNIVERSITY · SUMYУкрайна
- UNIWERSYTET IM. ADAMA MICKIEWICZA WPOZNANIU · PoznanПолша
- VILNIAUS UNIVERSITETAS · VilniusЛитва
- WORCESTER POLYTECHNIC INSTITUTE · WorcesterСъединени щати
Връзки
Данни: CORDIS, © Европейски съюз
